| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT06663332 A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants |
Trial sites expanded: 42 -> 47 locations |
| 2026-06-12 | NCT06663332 A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants |
date change Completion pushed: 2031-12-12 -> 2032-02-25 |
| 2026-06-12 | NCT05076175 A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to… |
date change Primary completion pushed: 2026-05-22 -> 2032-07-12 |
| 2026-06-12 | NCT05076175 A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to… |
date change Completion pushed: 2031-08-14 -> 2032-07-12 |
| 2026-06-11 | NCT07486921 Etrasimod as Prevention of Pouchitis |
Recruitment opened |
| 2026-06-09 | NCT07577856 A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative… |
Recruitment opened |
| 2026-06-09 | NCT07577856 A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative… |
Trial sites expanded: 0 -> 6 locations |
| 2026-06-09 | NCT07577843 A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease |
Recruitment opened |
| 2026-06-09 | NCT07577843 A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease |
Trial sites expanded: 0 -> 5 locations |
| 2026-06-06 | NCT06260163 A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active… |
date change Primary completion moved earlier: 2028-05-22 -> 2027-02-10 |
| 2026-06-06 | NCT06260163 A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active… |
date change Completion moved earlier: 2028-08-14 -> 2027-04-28 |
| 2026-06-06 | NCT05083182 A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile… |
date change Completion moved earlier: 2026-12-05 -> 2026-06-24 |
| 2026-06-06 | NCT07499232 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely… |
Trial sites expanded: 11 -> 30 locations |
| 2026-06-04 | NCT04338204 Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of… |
Trial completed |
| 2026-06-04 | NCT04338204 Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of… |
Enrollment reduced: 120 -> 102 participants |
| 2026-06-04 | NCT04338204 Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of… |
date change Primary completion moved earlier: 2026-03-30 -> 2025-09-30 |
| 2026-06-04 | NCT04338204 Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of… |
date change Completion moved earlier: 2026-03-30 -> 2025-09-30 |
| 2026-06-03 | NCT04624230 Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate… |
Trial sites reduced: 73 -> 68 locations |
| 2026-06-02 | NCT06654882 Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis |
date change Primary completion pushed: 2026-06 -> 2026-12 |
| 2026-05-28 | NCT07116967 Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With… |
Trial sites expanded: 357 -> 363 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-01 | NCT07616687 Optimal Care With Guselkumab in Crohn's Disease / OPTIM Study A Prospective Open Label… | Phase 4 | Not Yet Recruiting |
| 2026-05-22 | NCT07602517 Guselkumab for Overlap Inflammatory Bowel Disease and Spondyloarthritis | Not Yet Recruiting | |
| 2026-05-20 | NCT07598643 Modulation of the Immune System in Down Syndrome for Improved Outcomes and… | Phase 2 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07303686 | De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative… | Crohn Disease (CD) | Recruiting |
| NCT06520397 | Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus… | Crohn Disease | Recruiting |
| NCT06045754 | A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in… | Crohn's Disease | Recruiting |
| NCT06095128 | A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC) | Ulcerative Colitis | Recruiting |
| NCT05004727 | Multi-Center PAMPA Study | Psoriasis | Recruiting |
| NCT05270733 | Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics | Psoriasis | Recruiting |
| NCT07554820 | Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate… | Rheumatoid Arthritis | Recruiting |
| NCT06964113 | A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active… | Ulcerative Colitis | Recruiting |
| NCT05169593 | Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic… | Crohn Disease | Recruiting |
| NCT06916390 | GUselkumAb inteRvention and DIet evaluAtioN for Pouchitis | Pouchitis | Recruiting |
| NCT05858632 | Immune Spatial Features of Guselkumab Cutaneous Response | Psoriasis of Scalp | Recruiting |
| NCT07141004 | A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants… | Arthritis, Psoriatic | Recruiting |
| NCT07310095 | A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's… | Crohn Disease | Recruiting |
| NCT07406204 | Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA) | Alopecia Areata | Not Yet Recruiting |
| NCT04645355 | Guselkumab Immunogenetics | Psoriasis Guttate | Active, Not Recruiting |
| NCT07616687 | Optimal Care With Guselkumab in Crohn's Disease / OPTIM Study A Prospective Open Label… | Crohn Disease (CD) | Not Yet Recruiting |
| NCT07352566 | Utilization of a Microdevice for Psoriasis and Atopic Dermatitis | Psoriasis | Not Yet Recruiting |
| NCT04929210 | A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active… | Arthritis, Psoriatic | Active, Not Recruiting |
| Phase 3 | |||
| NCT06865417 | A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative… | Ulcerative Colitis | Recruiting |
| NCT04871191 | Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis | Granulomatosis With Polyangiitis | Recruiting |
| NCT03936361 | Statins In Intracerbral Hemorrhage | Intracerebral Hemorrhage | Recruiting |
| NCT07553182 | OLE Study With Filgotinib in JIA | Juvenile Idiopathic Arthritis (JIA) | Recruiting |
| NCT06408259 | Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in… | Multiple Sclerosis, Relapsing-Remitting | Recruiting |
| NCT06425549 | A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in… | Moderate to Severe Plaque Psoriasis | Recruiting |
| NCT07116967 | Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With… | Plaque Psoriasis | Recruiting |